141 related articles for article (PubMed ID: 37395800)
1. Deep learning-based diagnosis of disease activity in patients with Graves' orbitopathy using orbital SPECT/CT.
Yao N; Li L; Gao Z; Zhao C; Li Y; Han C; Nan J; Zhu Z; Xiao Y; Zhu F; Zhao M; Zhou W
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3666-3674. PubMed ID: 37395800
[TBL] [Abstract][Full Text] [Related]
2. New Multi-Parameters Combination of Technetium-99m-Diethylene-Triamine-Pentaacetate Orbital Single-Photon Emission Computed Tomography/Computed Tomography for the Evaluation of Graves' Orbitopathy Activity.
Sun L; Peng R; Sun R
Semin Ophthalmol; 2024 Jul; 39(5):387-393. PubMed ID: 38411131
[TBL] [Abstract][Full Text] [Related]
3. Monitoring and Predicting Treatment Response of Extraocular Muscles in Grave's Orbitopathy by
Jiang C; Deng Z; Huang J; Deng H; Tan J; Li X; Zhao M
Front Med (Lausanne); 2021; 8():791131. PubMed ID: 34977092
[No Abstract] [Full Text] [Related]
4. Effective encoder-decoder neural network for segmentation of orbital tissue in computed tomography images of Graves' orbitopathy patients.
Lee SH; Lee S; Lee J; Lee JK; Moon NJ
PLoS One; 2023; 18(5):e0285488. PubMed ID: 37163543
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of
Szumowski P; Abdelrazek S; Żukowski Ł; Mojsak M; Sykała M; Siewko K; Maliszewska K; Popławska-Kita A; Myśliwiec J
BMC Endocr Disord; 2019 Jan; 19(1):10. PubMed ID: 30658624
[TBL] [Abstract][Full Text] [Related]
6. Imaging of disease activity in Graves' orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores.
Galuska L; Leovey A; Szucs-Farkas Z; Szabados L; Garai I; Berta A; Balazs E; Varga J; Nagy EV
Nucl Med Commun; 2005 May; 26(5):407-14. PubMed ID: 15838422
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of activity of Graves' orbitopathy with multiparameter orbital magnetic resonance imaging (MRI).
Cheng J; Zhang X; Lian J; Piao Z; Zhou L; Gou X; Chen C; Chen L; Jiang K; Cheng J; Ji L; Hong N
Quant Imaging Med Surg; 2023 May; 13(5):3040-3049. PubMed ID: 37179934
[TBL] [Abstract][Full Text] [Related]
8. The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves' orbitopathy.
Zhao RX; Shi TT; Luo S; Liu YF; Xin Z; Yang JK
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35015696
[TBL] [Abstract][Full Text] [Related]
9. Application of quantitative orbital analysis to assess the activity of Graves' ophthalmopathy.
Li S; Liu YJ
Am J Nucl Med Mol Imaging; 2023; 13(6):259-268. PubMed ID: 38204608
[TBL] [Abstract][Full Text] [Related]
10. Neural network-based method for diagnosis and severity assessment of Graves' orbitopathy using orbital computed tomography.
Lee J; Seo W; Park J; Lim WS; Oh JY; Moon NJ; Lee JK
Sci Rep; 2022 Jul; 12(1):12071. PubMed ID: 35840769
[TBL] [Abstract][Full Text] [Related]
11. Learning fuzzy clustering for SPECT/CT segmentation via convolutional neural networks.
Chen J; Li Y; Luna LP; Chung HW; Rowe SP; Du Y; Solnes LB; Frey EC
Med Phys; 2021 Jul; 48(7):3860-3877. PubMed ID: 33905560
[TBL] [Abstract][Full Text] [Related]
12. Graves' orbitopathy: extraocular muscle/total orbit area ratio is positively related to the Clinical Activity Score.
Le Moli R; Pluchino A; Muscia V; Regalbuto C; Luciani B; Squatrito S; Vigneri R
Eur J Ophthalmol; 2012; 22(3):301-8. PubMed ID: 21786273
[TBL] [Abstract][Full Text] [Related]
13. Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis.
Marinò M; Ionni I; Lanzolla G; Sframeli A; Latrofa F; Rocchi R; Marcocci C
J Endocrinol Invest; 2020 Apr; 43(4):401-411. PubMed ID: 31691261
[TBL] [Abstract][Full Text] [Related]
14. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
Uslu-Beşli L; Kabasakal L; Sağer S; Cicik E; Asa S; Sönmezoğlu K
Nucl Med Commun; 2017 Nov; 38(11):964-970. PubMed ID: 28863123
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of orbital radiotherapy in moderate-to-severe active graves' orbitopathy including long-lasting disease: a retrospective analysis.
Choi JH; Lee JK
Radiat Oncol; 2020 Sep; 15(1):220. PubMed ID: 32958019
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of inflammatory activity in thyroid associated ophthalmopathy by SPECT/CT with 99mTc-DTPA].
Liu D; Xu X; Wen D; Tan J; Jiang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):457-460. PubMed ID: 29774886
[TBL] [Abstract][Full Text] [Related]
17. [The application of
Tang MT; Zeng XY; Li Y; Sun HT; Liu SY; Yuan X; Lu W
Zhonghua Yan Ke Za Zhi; 2021 Nov; 57(11):830-836. PubMed ID: 34743468
[No Abstract] [Full Text] [Related]
18. Efficacy of (99m)Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy.
Zhao R; Wang J; Deng J; Yang W; Wang J
Am J Nucl Med Mol Imaging; 2012; 2(2):242-7. PubMed ID: 23133815
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of thyroid disease using deep convolutional neural network models applied to thyroid scintigraphy images: a multicenter study.
Zhao H; Zheng C; Zhang H; Rao M; Li Y; Fang D; Huang J; Zhang W; Yuan G
Front Endocrinol (Lausanne); 2023; 14():1224191. PubMed ID: 37635985
[TBL] [Abstract][Full Text] [Related]
20. The development and validation of pathological sections based U-Net deep learning segmentation model for the detection of esophageal mucosa and squamous cell neoplasm.
Su F; Zhang W; Liu Y; Chen S; Lin M; Feng M; Yin J; Tan L; Shen Y
J Gastrointest Oncol; 2023 Oct; 14(5):1982-1992. PubMed ID: 37969831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]